News-Medical.Net on MSN17h
Unraveling resistance to CDK4/6 inhibitors in ovarian cancerOvarian cancer, a leading cause of death among gynecological malignancies, has a poor prognosis and low 5-year survival rate, ...
Polymer-coated nanoparticles loaded with therapeutic drugs show significant promise for cancer treatment, including ovarian ...
Newspoint on MSN12h
Good news for cancer patients, now this special antibody will cure this dreadful diseaseIgG antibodies are commonly used in cancer treatment. They help the body's immune system fight cancer and are being ...
Vietnam Investment Review on MSN10d
Innovent Dosed First Participant in Phase 3 Clinical Study of IBI354 for Platinum-resistant Ovarian CancerOvarian cancer is characterized by a pattern of frequent recurrence ... IBI354 has demonstrated remarkable anti-tumor ...
Innovent Biologics begins patient dosing in phase 3 study of IBI354 for platinum-resistant ovarian cancer: San Francisco Tuesday, March 25, 2025, 18:00 Hrs [IST] Innovent Biologic ...
A new anti-HER2 IgE antibody potentially offers new therapy options for treatment-resistant breast and ovarian cancers.
In addition, the investigators analyzed VPS35 expression levels in 24 patients with high grade serous ovarian cancer (HGSOC), who received treatment at MGCC.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback